AXGN241220C12500
- 1.65
- 0.000.00%
AxoGen Newsroom
All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy
Is Axogen (NASDAQ:AXGN) A Risky Investment?
How Much Upside Is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%
Top 10 Most Expensive Stocks (Only 1 Gets a Quant Sell)
Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript Summary
Insiders At Axogen Sold US$639k In Stock, Alluding To Potential Weakness
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $17
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
JMP Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $20
AxoGen | 10-Q: Q3 2024 Earnings Report
Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $18
Raymond James Says AxoGen Selloff 'Overdone,' Raises Price Target to $18
Express News | Axogen Shares Are Trading Lower. The Company Reported Q3 Financial Results
12 Health Care Stocks Moving In Thursday's Intraday Session
AxoGen Trading Resumes
AxoGen: Q3 Earnings Snapshot
AxoGen Reports Strong Q3 2024 Revenue Growth
AxoGen Non-GAAP EPS of $0.07 Beats by $0.06, Revenue of $48.6M Beats by $1.62M
Earnings Flash (AXGN) AXOGEN Reports Q3 EPS $0.07
AxoGen Reiterates FY24 Revenue View of $182M-$186M, Consensus $184.72M